Author: Tamura, Rodrigo Esaki; Said, Said Muhammad; de Freitas, Leticia Mussin; Rubio, Ileana Gabriela Sanchez
Title: Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies Cord-id: yvep0bl2 Document date: 2021_7_13
ID: yvep0bl2
Snippet: BACKGROUND: COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk factors associated with COVID-19, and treatment options focusing on diabetes patients and the use of metformin pre-admission and during hospitalization. METHODS: In this Brazilian single-center study
Document: BACKGROUND: COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk factors associated with COVID-19, and treatment options focusing on diabetes patients and the use of metformin pre-admission and during hospitalization. METHODS: In this Brazilian single-center study we evaluated 1170 patients hospitalized due to COVID-19. Diabetes patients (n = 188) were divided based on their use of pre-hospital and in-hospital metformin (non-met-group and met-group). RESULTS: In the total cohort most comorbidities were risk factors for orotracheal intubation and death. The use of chloroquine/hydroxychloroquine was significantly associated with increased death and intubation risk in uni- and multivariate analysis. Diabetes patients showed worst clinical feature compared with non-diabetes patients. In-hospital non-met-group had increased mortality (20.5%) compared to met-group (3.5%) (p = 0.0002) and univariable cox proportion hazard regression indicated in-hospital metformin reduced mortality (HR = 0.325, p = 0.035). Patients that used pre-hospital metformin showed lower severity parameters at hospital admission. (met-group: 2.45 ± 2.5; non-met-group: 4.25 ± 3.4). In all the groups older patients showed more severe clinical conditions and high risk of death and intubation. CONCLUSION: Even though this is a single-center study, results from other reports have shown a similar trend, indicating that patients that used metformin during hospitalization have a better prognosis and reduced risk of death. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-021-00695-8.
Search related documents:
Co phrase search for related documents- adjusted model and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- adjusted model and logistic regression analysis multivariate univariate analysis: 1
- adjusted model and long hospital stay: 1
- adjuvant therapy and admission prior: 1
- adjuvant therapy and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adjuvant therapy and logistic regression analysis: 1, 2, 3
- adjuvant therapy and low number: 1
- administrative record and logistic regression: 1, 2
- admission clinical feature and logistic regression: 1
- admission clinical feature and logistic regression analysis: 1
- admission metformin and logistic regression: 1
- admission prior and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- admission prior and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8
- admission prior and low number: 1, 2
- logistic regression analysis and long hospital stay: 1
- logistic regression analysis and low number: 1, 2, 3, 4, 5, 6
- logistic regression and long hospital stay: 1, 2, 3, 4, 5, 6, 7, 8
- logistic regression and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Co phrase search for related documents, hyperlinks ordered by date